Nucleic Acid-Modified Nanoparticles for Cancer Therapeutic Applications.

Area of Science:

• Biomedical Engineering
• Materials Science
• Nanotechnology

Background:

• Nanomaterials like metal oxides and carbon dots offer porous, catalytically active surfaces.
• Conjugating nucleic acids to nanoparticles creates hybrid nanostructures with enhanced functionalities.
• These hybrid systems are crucial for developing advanced therapeutic strategies.

Purpose of the Study:

• To review the application of nucleic acid-modified nanoparticle conjugates for cancer therapy.
• To highlight the synergistic properties of these hybrid composites for medical applications.
• To discuss their potential in targeted chemotherapy, gene therapy, and other cancer treatments.

Main Methods:

• Conjugation of nucleic acids (e.g., oligonucleotides) to various nanomaterials (nanoparticles, carbon dots, MOFs).
• Exploration of multimodal therapeutic activities including catalytic, photocatalytic, chemodynamic, photodynamic, and photothermal effects.
• Investigation of stimuli-responsive reconfiguration and specific recognition capabilities of nucleic acid components.

Main Results:

• Nucleic acid-nanoparticle conjugates exhibit multimodal catalytic/photocatalytic activities and high loading capacities.
• These conjugates demonstrate effective targeted cell permeation for cancer treatment.
• Hybrid composites show cooperative synergistic properties, enhancing therapeutic efficacy.

Conclusions:

• Nucleic acid-nanoparticle conjugates represent a promising platform for multimodal cancer therapy.
• Their ability to combine targeting, catalysis, and stimuli-responsiveness offers new avenues for treatment.
• Further research into these conjugates could revolutionize cancer treatment and gene therapy approaches.